Trial Profile
Does Liposomal Bupivacaine Improve Postoperative Pain Control After One Level Posterior Spinal Fusion With Instrumentation
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 25 Feb 2022
Price :
$35
*
At a glance
- Drugs Bupivacaine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 22 Feb 2022 Planned End Date changed from 1 May 2022 to 1 May 2024.
- 22 Feb 2022 Planned primary completion date changed from 1 Jan 2022 to 1 Jan 2024.
- 11 Jan 2021 Planned End Date changed from 1 May 2021 to 1 May 2022.